Executive Summary
The grant proposal covers reducing lung cancer among Aboriginal and Torres Strait Islander adults in South Australia. Indigenous people had slightly high rates of lung cancer than non-Indigenous. Hence, the project aims to reduce the rate of lung cancer infection and deaths among Aboriginal and Torres Strait Islander people in South Australia.
The project rationale for funding would result in the best health outcomes for patients, reduce deaths associated with lung cancer, and promote further progress in controlling lung cancer.
The project has three objectives, which include developing an effective educational program, early detection, and tobacco cessation. The project would have positive impacts if these objectives remain core for the entire project life of five years.
There are several actions or strategies for proposed interventions. These would ensure that the project achieves intended results. Strategies require stakeholders’ collaboration, adequate resources, time, and expected outcomes.
The project evaluation outcomes would show validity, reliability, sensitivity, and feasibility features of the instrument, which would be appropriate for indicating the health-related quality of life, patient satisfaction with the quality of care, socioeconomic challenges of cancer, and overall health system performance.
Goal Statement
To reduce the rate of lung cancer infection and deaths among Aboriginal and Torres Strait Islander people in South Australia
In the year 2009, lung cancer became the fifth most diagnosed cancer in Australia (Australian Institute of Health and Welfare & Australasian Association of Cancer Registries, 2012). It accounted for 8.9% of new cases of cancer in the country. The mortality rate due to lung cancer was critically higher among Aboriginal and Torres Strait Islander people (Indigenous) in remote locations, who were medically underserved than non-Indigenous.
Rationale
Improve disparity
Lung cancer continues to pose a significant public health challenge and funding is necessary to improve the disparity of the diseases among Aboriginal and Torres Strait Islander people.
Achieve further progress
Funding can ensure that stakeholders achieve further progress through sustaining current efforts to control lung cancer among Aboriginal and Torres Strait Islander people in South Australia, particularly among populations who are medically underserved and are at the bottom of the socioeconomic bracket.
Improve health outcomes
Funding would result in improved health outcomes, reduce deaths associated with lung cancer, and improve quality of life among Aboriginal and Torres Strait Islander people through early detection, treatment, and reducing risk factors.
Project Objectives and Impact Measures
Method – Proposed Intervention
Objective 1: To develop an appropriate education program for Aboriginal and Torres Strait Islander people in South Australia who have lung cancer or are susceptible to lung cancer in order to increase public awareness by 50 percent within the next five years
Objective 2: Early Detection – By 2019, enhance the number of Aboriginal and Torres Strait Islander adults who get yearly lung cancer screening from 40 percent to 80 percent in South Australia.
Objective 3: Tobacco Cessation – By 2019, increase the number of Aboriginal and Torres Strait Islander people in South Australia who work in a smoke-free environment from 15 percent to 90 percent by encouraging a comprehensive smoke-free air at workplace.
Outcome Evaluation
The rate of lung cancer among Aboriginal and Torres Strait Islander in South Australia adults has remained significantly higher relative to non-Indigenous (Australian Institute of Health and Welfare, 2011). Hence, outcome evaluation in this project is extremely critical for lung cancer stakeholders. The project outcome should indicate the improved quality of care, and reduce health disparities.
The situation could be assessed on endpoint measures to set priorities for future lung cancer evaluation. The validity, reliability, sensitivity, and feasibility features of the instrument would be appropriate for indicating the health-related quality of life, patient satisfaction with the quality of care, the socioeconomic challenge of cancer and overall health system performance.
Specifically, outcome measures will concentrate on improved survival. The number of cancer patients who will get relief from the project would reflect the relevance of the intervention.
Overall, the patient experience would show the effectiveness of the program, diversity, and factors that have led to disease tolerance. The study would show causes for patient variations. In addition, the project would aim to improve the quality of life and health outcomes for all (Anisoglou et al., 2013).
References
Anisoglou,S., Asteriou, C., Barbetakis, N., Kakolyris, S., Anastasiadou, G., and Pnevmatikos, I. (2013). Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure. Hippokratia, 17(1), 60–63.
Australian Institute of Health and Welfare. (2011). Lung cancer in Australia. Canberra: AIHW.
Australian Institute of Health and Welfare & Australasian Association of Cancer Registries. (2012). Cancer in Australia: an overview, 2012. Cancer series no. 74. Cat. no. CAN 70. Canberra: AIHW.
Bernardes, M., Whop, J., Garvey, G., and Valery, C. (2012). Health service utilization by indigenous cancer patients in Queensland: a descriptive study. International Journal for Equity Health, 11, 57. Web.
Chong, A., and Roder D. (2010). Exploring differences in survival from cancer among Indigenous and non-Indigenous Australians: implications for health service delivery and research. Asian Pacific Journal of Cancer Prevention, 11(4), 953-61.
Davidson, M., Jiwa M., Digiacomo, L., McGrath, J., Newton, J., Durey, J.,…Thompson, C. (2013). The experience of lung cancer in Aboriginal and Torres Strait Islander peoples and what it means for policy, service planning and delivery. Australian Health Review, 37(1), 70-8. Web.
Emery, D., Walter, M., Gray, V., Sinclair, C., Howting, D., Bulsara, M.,…Holman, D. (2013). Diagnosing cancer in the bush: a mixed methods study of GP and specialist diagnostic intervals in rural Western Australia. Family Practice, 30(5), 541-50. Web.
Fairley, T., Tai, E., Townsend, J., Stewart, S., Steele, C., Davis, P., and Underwood, M. (2010). Racial/Ethnic Disparities and Geographic Differences in Lung Cancer Incidence — 38 States and the District of Columbia, 1998–2006. Morbidity and Mortality Weekly Report, 59(44), 1434-1438.
Fotaki, M., Roland, M., Boyd, A., McDonald, R., Scheaff, R., and Smith, L. (2008). What benefits will choice bring to patients? Literature review and assessment of implications. Journal of Health Services Research & Policy, 13(3), 178-84. Web.
Glasgow, N. (2008). Systems for the management of respiratory disease in primary care – an international series: Australia. Primary Care Respiratory Journal, 17(1), 19- 25. Web.
Mirsadraee, S., Oswal, D., Alizadeh, Y., Caulo, A., and van Beek, E. (2012). The 7th lung cancer TNM classification and staging system: Review of the changes and implications. World J Radiol., 4(4), 128–134. Web.
Moore, A., Baumann, F., Foliaki, S., Goodman, T., Haddock, R., Maraka, R.,…Sobue, T. (2010). Cancer epidemiology in the pacific islands – past, present and future. Asian Pacific Journal of Cancer Prevention, 11(Suppl 2), 99-106.
Roder, D., and Currow, D. (2009). Cancer in aboriginal and Torres Strait Islander people of Australia. Asian Pacific Journal of Cancer Prevention, 10(5), 729-33.